Most people won't need a COVID-19 vaccine booster shot for years, vaccination experts predict
The U.S. Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices is meeting next week to discuss whether immunocompromised Americans should be authorized to receive a third dose of COVID-19 vaccine, and Pfizer said last week it will seek regulatory approval for an eventual third booster shot of its vaccine amid the rapidly spreading Delta variant. Israel said this week it will begin administering a third Pfizer dose to severely immunocompromised adults, and Britain has announced a plan to administer booster shots beginning in September.
The rapid spread of the Delta mutation among unvaccinated pockets of the U.S. combined with Pfizer's announcement "has unleashed third-dose panic among the vaccinated," Politico reports. But global public health officials are outraged that vaccine-rich countries would consider third shots before health care workers in many countries have gotten their first dose of a COVID-19 vaccine. And most U.S. public health and government officials say people won't need a booster shot now or anytime soon.
"There's no evidence right now that the general population needs a booster dose because we're not seeing evidence of waning immunity or substantially reduced effectiveness against the Delta variant," William Moss, executive director of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health, tells Politico. "I think for most people, outside those special populations, the immunocompromised and maybe the elderly — I think most people's immunity is going to last years, to be honest." He said if a variant manages to evade the vaccines, a booster shot may be needed, but he guessed it will be three or four years, or longer, before most people need an extra dose.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"I haven't seen evidence that a booster would be indicated for anybody, including the immunocompromised," Helen Boucher, an infectious-disease doctor at Tufts Medical Center in Boston, tells The Washington Post. She said the best way to protect immunocompromised people is to make sure everyone around them is vaccinated.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
How close are we to a norovirus vaccine?
Today's Big Question A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year
By David Faris Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published